Corvus Pharmaceuticals
CRVS
CRVS
47 hedge funds and large institutions have $12.4M invested in Corvus Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 12 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
7.54% less ownership
Funds ownership: 54.99% → 47.45% (-7.5%)
25% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 12
33% less capital invested
Capital invested by funds: $18.5M → $12.4M (-$6.08M)
Holders
47
Holding in Top 10
1
Calls
$40K
Puts
$30K
Top Buyers
| 1 | +$139K | |
| 2 | +$87.3K | |
| 3 | +$56.3K | |
| 4 |
TI
Telemetry Investments
New York
|
+$50.6K |
| 5 |
B
Bailard
Foster City,
California
|
+$33K |
Top Sellers
| 1 | -$3.27M | |
| 2 | -$346K | |
| 3 | -$159K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$18.5K |
| 5 |
Goldman Sachs
New York
|
-$18.3K |